Dive into additional groundbreaking treatment approaches for triple-negative breast cancer (TNBC) in this tumor board, the second in a series focused on TNBC. This multidisciplinary tumor board discusses a patient with advanced TNBC and how novel anti-TROP2 antibody-drug conjugates (ADCs) therapy may play a role.
Claim credit: https://www.achlcme.org/tnbc-case-challenge-onctube
Access the three-part series: https://www.achlcme.org/triple-negative-breast-cancer
Advertisement